Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Vaccination With Dendritic Cell/Tumor Fusions With Autologous Stem Cell Transplants in Patients With Multiple Myeloma

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborators:
Massachusetts General Hospital
Dana-Farber Cancer Institute
Brigham and Women's Hospital
Rambam Health Care Campus
Information provided by (Responsible Party):
David Avigan, MD, Beth Israel Deaconess Medical Center
ClinicalTrials.gov Identifier:
NCT00458653
First received: April 10, 2007
Last updated: January 15, 2016
Last verified: January 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: December 2016
  Primary Completion Date: April 2012 (Final data collection date for primary outcome measure)